نتایج جستجو برای: febrile neutropenia drug

تعداد نتایج: 606432  

Asghar Zare, azam Sadat Hashemi, Fatemeh Behnaz, Neda Najafi,

Abstract Objective Fever and neutropenia are a common complication of chemotherapy in cancer. It is usually managed by hospitalization and empiric administration of antibiotics. Use of Fluroquinolones is limited because of joint/cartilage toxicity. This study attempted to compare the efficacy of oral ciprofloxacin with intravenous ceftazidim in low risk febrile neutropenic lymphocytic leukemi...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007
Elio Castagnola Vincenzo Fontana Ilaria Caviglia Silvia Caruso Maura Faraci Francesca Fioredda Maria Luisa Garrè Cristina Moroni Massimo Conte Giuseppe Losurdo Franca Scuderi Roberto Bandettini Paolo Tomà Claudio Viscoli Riccardo Haupt

BACKGROUND The purpose of our study was to evaluate the incidence and clinical characteristics of febrile episodes during neutropenia following chemotherapy in children with cancer. PATIENTS AND METHODS A prospective, 3-year single-center observational study of periods of neutropenia was performed. Epidemiology and clinical diagnoses of febrile episodes occurring during the neutropenic period...

Journal: :The oncologist 2005
Gary H Lyman Christopher H Lyman Olayemi Agboola

Neutropenia and its complications, including febrile neutropenia, are major dose-limiting toxicities of systemic cancer chemotherapy. A number of studies have attempted to identify risk factors for neutropenia and its consequences to develop predictive models capable of identifying patients at greater risk for such complications and to guide more effective and cost-effective applications of the...

2017
Theis Aagaard Ashley Roen Gedske Daugaard Peter Brown Henrik Sengeløv Amanda Mocroft Jens Lundgren Marie Helleberg

Journal: :Haematologica 2013
Diana Averbuch Christina Orasch Catherine Cordonnier David M Livermore Malgorzata Mikulska Claudio Viscoli Inge C Gyssens Winfried V Kern Galina Klyasova Oscar Marchetti Dan Engelhard Murat Akova

Owing to increasing resistance and the limited arsenal of new antibiotics, especially against Gram-negative pathogens, carefully designed antibiotic regimens are obligatory for febrile neutropenic patients, along with effective infection control. The Expert Group of the 4(th) European Conference on Infections in Leukemia has developed guidelines for initial empirical therapy in febrile neutrope...

2016

Febrile neutropenia (FN) is characterized by a decrease in neutrophils number to values below 500 cells/ mm3 and an occurrence of fever higher or similar to38.3oC. It commonly occurs in cancer patients as a result of chemotherapy regimens. Chemotherapy destroys carcinogenic cells but also attacks in many cases some normal cells including essential elements of the immune system. Fever is one of ...

Journal: :Journal of paediatrics and child health 2013
Aditi Vedi Richard Cohn

The purpose of this study is to determine whether, in low-risk febrile neutropenic paediatric populations, oral antibiotics are as effective as intravenous antibiotics in obtaining resolution of the febrile neutropenic episode. A comprehensive literature search of MEDLINE, EMBASE and CENTRAL identified prospective, randomised controlled trials comparing oral antibiotics with intravenous antibio...

Journal: :Haematologica 2011
Matti Vänskä Irma Koivula Sari Hämäläinen Kari Pulkki Tapio Nousiainen Esa Jantunen Auni Juutilainen

We evaluated pentraxin 3 as a marker for complications of neutropenic fever in 100 hematologic patients receiving intensive chemotherapy. Pentraxin 3 and C-reactive protein were measured at fever onset and then daily to day 3. Bacteremia was observed in 19 patients and septic shock in 5 patients (three deaths). In comparison to C-reactive protein, pentraxin 3 achieved its maximum more rapidly. ...

Journal: :international journal of hematology-oncology and stem cell research 0
sarah mousavi department of clinical pharmacy and pharmacy practice, faculty of pharmacy and pharmaceutical sciences, isfahan university of medical sciences, isfahan, iran mina dadpoor pharm d student, faculty of pharmacy and pharmaceutical sciences, isfahan university of medical sciences, isfahan, iran farzaneh ashrafi hematology and medical oncology department, school of medicine, isfahan university of medical sciences, isfahan, iran acquired immunodeficiency research center, isfahan university of medical sciences, isfahan, iran

background: granulocyte colony stimulating factors (gcsf) are high cost agents commonly recommended for primary and secondary prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia. gcsfs have been shown to be beneficial in some patient subgroups, although they are probably overused in clinical settings. the american society of clinical oncology (asco) guidelines summarize curr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید